Screener
Agilon Health AGL Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Agilon Health in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The source filing: Agilon Health’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053355
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Total liabilities | 1,363,809 | 1,144,556 |
| Commitments and contingencies | ||
| Stockholders' equity (deficit): | ||
| Common stock, $0.01 par value: 2,000,000 shares authorized; 16,785 and 16,589 shares issued and outstanding, respectively | 168 | 166 |
| Additional paid-in capital | 2,138,657 | 2,103,976 |
| Accumulated deficit | (1,911,452) | (1,978,324) |
| Accumulated other comprehensive income (loss) | 154 | 916 |
| Total stockholders’ equity (deficit) | 227,527 | 126,734 |
Item 1. Financial Statements
FAQ
- What is Agilon Health's common stock?
- Agilon Health (AGL) reported common stock of 2B in Q2 2026.
- How has Agilon Health's common stock changed year-over-year?
- Agilon Health's common stock decreased by 0.0% year-over-year, from 2B to 2B.
- What is the long-term trend for Agilon Health's common stock?
- Over 5 years (2020 to 2025), Agilon Health's common stock has grown at a 280.9% compound annual growth rate (CAGR), from 2.5M to 2B.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Agilon Health's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude